View Item 

Show simple item record

Evaluation of Retinoblastoma and Ki-67 Immunostaining as Diagnostic Markers of Benign and Malignant Parathyroid Disease
dc.contributor.authorThompson, Norman W.en_US
dc.contributor.authorSandelin, Kerstinen_US
dc.contributor.authorLarsson, Catharinaen_US
dc.contributor.authorGrimelius, Larsen_US
dc.contributor.authorTeh, Bin Teanen_US
dc.contributor.authorAspenblad, Ullaen_US
dc.contributor.authorAuer, Gerten_US
dc.contributor.authorTwigg, Stephenen_US
dc.contributor.authorFarnebo, Filipen_US
dc.contributor.authorFarnebo, Lars-Oveen_US
dc.date.accessioned2006-09-08T20:18:37Z
dc.date.available2006-09-08T20:18:37Z
dc.date.issued1999-01en_US
dc.identifier.citationFarnebo, Filip; Auer, Gert; Farnebo, Lars-Ove; Teh, Bin Tean; Twigg, Stephen; Aspenblad, Ulla; Thompson, Norman W.; Grimelius, Lars; Larsson, Catharina; Sandelin, Kerstin; (1999). "Evaluation of Retinoblastoma and Ki-67 Immunostaining as Diagnostic Markers of Benign and Malignant Parathyroid Disease." World Journal of Surgery 23(1): 68-74. <http://hdl.handle.net/2027.42/42410>en_US
dc.identifier.issn0364-2313en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/42410
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9841766&dopt=citationen_US
dc.description.abstractRID="" ID="" <E5>Correspondence to:</E5> F. Farnebo, M.D., Ph.D.en_US
dc.format.extent625553 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlag; by the Société Internationale de Chirugieen_US
dc.subject.otherLegacyen_US
dc.titleEvaluation of Retinoblastoma and Ki-67 Immunostaining as Diagnostic Markers of Benign and Malignant Parathyroid Diseaseen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelSurgery and Anesthesiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Surgery, University ofMichigan Hospital, 1500 Medical Center Drive, TC 2920-D, AnnArbor, Michigan 48109, USA, USen_US
dc.contributor.affiliationotherDepartment of Molecular Medicine,Endocrine Tumor Unit, CMM L8:01, Karolinska HospitalSE-171 76 Stockholm, Sweden, SEen_US
dc.contributor.affiliationotherDepartment of Clinical Pathology,Karolinska Hospital, SE-171 76 Stockholm,Sweden, SEen_US
dc.contributor.affiliationotherDepartment of Molecular Medicine,Endocrine Tumor Unit, CMM L8:01, Karolinska HospitalSE-171 76 Stockholm, Sweden, SEen_US
dc.contributor.affiliationotherKolling Institute of Medical Research,Royal North Shore Hospital, Sydney, New South Wales2065, Australia, AUen_US
dc.contributor.affiliationotherDepartment of Molecular Medicine,Endocrine Tumor Unit, CMM L8:01, Karolinska HospitalSE-171 76 Stockholm, Sweden, SEen_US
dc.contributor.affiliationotherDepartment of Surgery, KarolinskaHospital, SE-171 76 Stockholm, Sweden, SEen_US
dc.contributor.affiliationotherDepartment of Surgery, KarolinskaHospital, SE-171 76 Stockholm, Sweden, SEen_US
dc.contributor.affiliationotherDepartment of Clinical Pathology,Karolinska Hospital, SE-171 76 Stockholm,Sweden, SEen_US
dc.contributor.affiliationotherDepartment of Clinical Pathology,Karolinska Hospital, SE-171 76 Stockholm,Sweden, SEen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid9841766en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/42410/1/268-23-1-68_23n1p68.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/s002689900567en_US
dc.identifier.sourceWorld Journal of Surgeryen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
268-23-1-68_23n1p68.pdf
Size:
610.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.